RxDoctor Payments Data

Gina Buttner

Family · Slidell, LANPI 1225784770

Payments from drug & device makers

$4,530in general payments, 2019–2025

Across 264 payments — averaging $17.16 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$746
  • Novo Nordisk$703
  • GSK$491
  • Lilly USA, LLC$447
  • Exact Sciences$245
  • Pfizer$159
  • plus $2K from 29 others

What the payments were for

  • Food & beverage$4,530100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$4,530 in reported general payments places this provider in the 85th percentile of 3,610 family providers in Louisiana.

See all family providers in Louisiana

Medicare billing

Part B allowed, 2024
$17,502
Medicare patients
147
Services billed
235

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin36$39,542
EliquisApixaban50$38,943
OzempicSemaglutide22$28,750
MounjaroTirzepatide18$18,534
Trelegy ElliptaFluticasone/Umeclidin/Vilanter16$11,603
XareltoRivaroxaban11$9,497
SymbicortBudesonide/Formoterol Fumarate13$4,358
Albuterol Sulfate HfaAlbuterol Sulfate70$2,295
Lantus SolostarInsulin Glargine,hum.Rec.Anlog16$1,486
Potassium Chloride75$1,103
Nano 2nd Gen Pen NeedlePen Needle, Diabetic15$975
Levothyroxine Sodium76$816
Atorvastatin Calcium105$788
Pantoprazole Sodium108$757
Amlodipine Besylate159$732

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance$76$39,54236 claims
PfizerEliquis$159$38,94350 claims
Novo NordiskOzempic$703$28,75022 claims
Lilly USA, LLCMounjaro$447$18,53418 claims
GSKTrelegy Ellipta$491$11,60316 claims
AstraZenecaSymbicort$746$4,35813 claims
Amneal Pharmaceuticals LLCLevothyroxine Sodium$31$81676 claims
Almatica Pharma LLCSertraline Hcl$42$20235 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 3,610 family providers in Louisiana.

Other family in Slidell

See the full list for Louisiana

Where these figures come from

Is this you, or does something look wrong? →